P02_FY26 ETMPM and TENS Procurement Program_RFI_Template.docx

Request For Information (RFI)

From:

· Department of Veterans Affairs (VA)

· Veterans Health Administration (VHA)

· National Prosthetic & Sensory Aids Service (PSAS)

· Enterprise Procurement Office (EPO)

· Acquisition Services Division Four Team Delta (AS4D) Subject:

FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Requirement with the inclusion of the new Electro-Therapeutic Modalities for Pain Management (ETMPM) Requirement Presolicitation request For Information (RFI).

Executive Summary:

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), is initiating market research in preparation for the Fiscal Year 2026 (FY26) procurement cycle for the Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Units and Accessories. This procurement effort represents a significant modernization and expansion of the VA’s national non-opioid pain-management programs. This procurement effort consolidates the requirements from the legacy contract number 36C79122D0005, which is currently suppling the TENS units and accessories, and it expands the product line to include Interferential Current (IFC) units, Short Wave Diathermy units, Neuromodulation devices, and associated electrodes, applicators, batteries, chargers, cables, and clinical-use accessories. The expanded scope of this procurement effort supports VHA’s ongoing transition toward comprehensive, evidence-based, non-pharmacological pain management solutions accessible across all Veterans Integrated Services Networks (VISNs), 168 Veterans Affairs Medical Centers (VAMCs), and more than 1,000 outpatient clinics and federal partner sites. The key objectives of this procurement are:

· Ensure uninterrupted, nationwide availability of ETMPM and TENS devices across all VA facilities.

· Standardize clinical equipment to promote consistency of care, safety, and treatment outcomes for Veterans.

· Establish stable, volume-based Firm-Fixed-Price (FFP) Indefinite-Delivery/Indefinite-Quantity (IDIQ) contracts to secure predictable pricing across the full contract lifecycle.

· Improve supply chain efficiency through centralized distribution at the Denver Logistics Center (DLS) and electronic order processing via ROES.

· Expand product availability to include device types supporting multiple modalities of non-opioid pain management.

· Reduce program risk by eliminating rental, lease, subscription, or usage-based business models that conflict with VA acquisition regulations.

· Maintain Veteran safety through FDA-compliant devices, OEM warranty standards, and strict prohibition of gray-market goods.

Contract Line Item Numbers (CLINs) & Sub-Line Item Numbers (SLINs):

1. The anticipated FY26 solicitation will include the following CLINs, which represent the primary therapeutic devices being procured, such as TENS units, IFC devices, Shortwave Diathermy devices (e.g., thermal and non‑thermal), and portable neuromodulation devices. Each CLIN corresponds to a distinct medical device with its own required performance parameters and technical characteristics. CLINs are individually priced, technically evaluated, and serve as the basis for warranty, regulatory compliance, and product performance requirements.

a. CLIN Naming Convention: The program employs clearly defined naming conventions to ensure traceability and administrative clarity as follows

i. CLINs use a four‑digit alphanumeric identifier (e.g., X001, X002).

ii. The first character of the CLIN indicates the period of performance:

a) “0” = Base Year;

b) “1–4” = Option Years One (1) through Four (4); and

c) “X” = Pre‑award or solicitation‑phase CLIN identification applicable across all periods of performance until the time of award.

d) The last three digits uniquely identify the device type.

2. SLINs: SLINs represent the accessories, components, and consumables associated with each device, such as electrodes, lead wires, chargers, and other device‑specific accessories.

SLINs may be informational only (e.g., tracking of product categories only) or priced (e.g., separately priced products for ordering of specific accessory items). SLINs inherit the universal MTRs applicable to the associated CLIN but also contain additional accessory‑specific salient characteristics for example, electrode dimensions, material requirements, gel properties, quantities per package, or skin‑sensitivity variants.

a. SLIN Naming Convention:

i. SLINs extend the CLIN with two (2) additional alphanumeric characters (e.g., X001AA, X001AB).

ii. Alphabetic SLINs (AA–ZZ, excluding I and O) are used for priced deliverables, such as the accessories associated with the CLIN.

iii. Numeric SLINs (01–99) are used for informational tracking purposes only, administrative purposes, or unpriced product categories.

iv. SLINs are always subordinate to their parent CLIN and cannot exist independently.

3. The anticipated FY26 solicitation will include the following CLINs/SLINs:

· CLIN X001 = Portable TENS Device;

· SLIN X001AA = TENS Electrodes (2 in.)

· SLIN X001AB = TENS Electrodes (2 in. x 4 in.)

· SLIN X001AC = TENS Electrodes (2 in. & 2 in. x 4 in., Sensitive Skin)

· SLIN X001AD = TENS Electrodes (Offeror Proposed Alternate Options)

· CLIN 0002 = PORTABLE INTERFERENTIAL CURRENT (IFC) Device;

· SLIN 0002AA = IFC Electrodes (2 in.)

· SLIN 0002AB = IFC Electrodes (2 in. x 4 in.)

· SLIN 0002AC = IFC Electrodes (2 in. & 2 in. x 4 in., Sensitive Skin)

· SLIN 0002AD = IFC Electrodes (Offeror Proposed Alternate Options)

· CLIN 0003 = Shortwave Diathermy Device (Thermal)

· CLIN 0004 = Shortwave Diathermy Device (Non‑thermal)

· CLIN 0005 = Portable Neuromodulation Device - For Headache Disorders

Additional Information:

· Respondents to this RFI shall not submit proposals, pricing, or quotes at this time;

· This RFI does not obligate the Government to issue a solicitation or award any contract for this requirement;

· Responding to an RFI is a voluntary action taken by the Respondent, therefore, the Government will not reimburse Respondents for any costs incurred associated with preparing a response to this RFI; and

· Respondents to this RFI shall not submit to the Government any proprietary or classified information under any circumstances.

Disclaimer:

This Presolicitation Notice is issued solely for market research purposes and informational planning and strategy. It does not constitute a solicitation or a promise to issue a solicitation. No contract award will result from this notice.

Government Designated Point of Contact:

John Overstake Contract Specialist Department of Veterans Affairs Email: john.overstake@va.gov Phone: (720) 497-2304 RFI Respondent Instructions:

All interested Respondents to this RFI are respectfully requested to complete the text fields provided and follow these document submission steps:

1. Complete Personal Identification Fields: Fill out all respondent/company information fields;

2. Convert the RFI MS WORD document into an Adobe PDF document;

3. Digitally Sign and Date the Adobe PDF Document: Affix a digital signature and enter the date in the signature block;

4. Email the Completed and Signed Adobe PDF document: Send the signed/dated PDF document as an attachment to an email message addressed to:

· ATTN: Contract Specialist – John Overstake

· Email: john.overstake@va.gov

· Subject Line: “RFI Response – ETMPM/TENS Program – [Your Company’s Legal Name]”; and

5. Response Deadline: All responses to this RFI are due on or before, but no later than September 4, 2026 at 3:00 PM CST. Late submissions may not be reviewed and shall not receive a Government response.

SECTION A: MARKET RESEARCH DATA

A.1 RESPONDENT INFORMATION:

1.1 Company’s Legal Business Name:

1.2 Company’s Physical Address:

1.3 Company's URL:

1.4 Company's Primary Point of Contact (POC) Name:

1.5 Company's Primary POC’s Title:

1.6 Company's Primary POC’s Phone No.:

1.7 Company's Primary POC’s Email Address:

1.8 Company's System For Award Management UEI:

1.9 Company's Cage Code:

1.10 Company's Business Size For NAICS Code: 339112:

1.11 Company’s Socioeconomic Subgroup Status:

1.12 Company’s Status (Manufacturer or Reseller/Distributor):

1.13 Company's Primary POC’s Digital Signature:

1.14 Date Signed:

A.2 RESPONDENT PRODUCT INFORMATION

2.1 Company’s Products: Please complete the table below by providing detailed information for each product your company is offering for potential acquisition by the Department of Veterans Affairs (VA). Include all known technical characteristics, performance specifications, and any additional descriptive information that supports market research efforts. Ensure that each field is completed as thoroughly as possible to facilitate accurate review. If a particular field does not apply, enter "N/A".

(List As Necessary) Company’s Product Offerings

(List As Necessary) Company’s Product Offerings

Questions For Industry:

The Government is respectfully requesting all industry participants who are interested in this requirement and likely to be prospective Offerors to the resultant solicitation for this requirement to respond to the following questions:

1. HCPCS Utilization: What is your assigned Healthcare Common Procedure Coding System (HCPC) utilization for your devices that you intend to offer to the Government for purchase for CLINs X001 - X005?

2. HCPCS Utilization: What is your assigned Healthcare Common Procedure Coding System (HCPC) utilization for your devices that you intend to offer to the Government for purchase for SLINs X001AA/X001AB/X001AC/X001AD?

3. HCPCS Utilization: What is your assigned Healthcare Common Procedure Coding System (HCPC) utilization for your devices that you intend to offer to the Government for purchase for SLINs X002AA/X001AB/X001AC/X001AD?

4. CMS‑Assigned HCPCS Codes: What is your assigned Centers for Medicare & Medicaid Services (CMS) HCPC for your devices that you intend to offer to the Government for purchase for CLINs X001, X006, X007, and X008?

5. If No CMS Assignment Exists: If no assignment, what HCPC code do you see most often utilized for your devices that you intend to offer to the Government for purchase for CLINs X001, X006, X007, and X008?

6. Anticipated Product Delivery Lead‑Times: The Government must complete solicitation development, perform proposal evaluations, and make source selection decisions, and execute the resultant contracts for this requirement prior to expiration of legacy contract number 36C79122D0005 on January 19, 2027.

a. What are your organization’s standard commercial delivery lead‑times?

b. If awarded a contract under this program, what delivery lead‑time will be required from the date of award to first delivery to the VA’s Denver Logistics Center (DLS) in Golden, Colorado?

5. End-Product(s) Country-Of-Origin Representation: What are the Country‑of‑Origin (COO) for each CLIN and SLIN you intend to offer the VA under the FY26 Recompete of the Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program? Please identify the COO of the end‑product you intend to offer the VA, as defined under FAR Part 25. Indicate whether the end-product/item is a Domestic End Product under the Buy American Act (BAA), a Trade Agreements Act (TAA) ‑ compliant end-product, or non‑compliant BAA/TAA end-product. Please also confirm whether your company can provide formal COO certification for all offered end-products at the time of solicitation.

Closing Remarks:

The Department of Veterans Affairs (VA) extends its deepest appreciation to all industry partners for their participation and heightened interest in the FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Program and the expanded Electro‑Therapeutic Modalities for Pain Management (ETMPM) Requirement.

The VA further acknowledges the professionalism and engagement demonstrated during the VA’s Industry Days held at the Denver Logistics Services (DLS) facility in Golden, Colorado from February 24–26, 2026. Your presence and contributions during these sessions reflect a meaningful and shared commitment to improving non‑opioid pain‑management solutions for this great nation’s Veterans.

The VA recognizes and values the time, energy, and thoughtful collaboration provided by prospective suppliers during this critical early phase of the acquisition process. Your awareness and industry expertise play an essential role in shaping a competitive, transparent, and well‑informed procurement environment that ensures America’s Veterans receive safe, reliable, clinically effective therapeutic devices that support their long‑term health and well‑being. The insights shared by industry partners are instrumental to the VA’s planning efforts, helping us refine requirements, enhance acquisition clarity, and uphold the highest standards of clinical readiness and supply chain resilience.

This procurement effort supports a solemn national promise reaffirmed through every VA program: “To care for those who have borne the battle in service to the United States.” The modernization of the TENS requirement and its strategic integration with advanced ETMPM technologies reflect the VA’s dedication to expanding evidence‑based, non-pharmacological modalities that directly enhance the quality of life for millions of Veterans living with acute and chronic pain conditions. Meeting this mission cannot occur without the dedication, capability, and integrity of committed private‑sector partners.

The Government sincerely appreciates industry’s continued engagement and the comprehensive market feedback received during this RFI stage. As this requirement progresses toward formal solicitation, we look forward to the ongoing partnership of qualified suppliers who share our commitment to delivering exceptional clinical tools, strengthening national logistics support, and honoring the sacrifice of those who served. Your continued collaboration enhances the VA’s ability to execute a timely, high‑quality, and mission‑aligned procurement process that will enable consistent access to critical pain‑management technologies across all VA medical facilities.

All future updates, timelines, and acquisition instructions will be communicated exclusively through the Governmentwide Point of Entry (GPE) at www.sam.gov. The Department of Veterans Affairs extends its sincere gratitude for your professionalism, attentiveness, and dedication to our Veterans. We value your partnership and look forward to your continued participation as this important requirement advances toward formal competition.

*** PRE-DECISIONAL ***

This is NOT a Request for Quote, Invitation for Bid, or a Request for Proposal image1.png